Shengtai Medicine
Shengtai Medicine, also known as Shengtai Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 2001, the company has made significant strides in the development and production of high-quality medicinal products, focusing on both traditional and modern therapeutic solutions. With a strong operational presence across various regions in Asia, Shengtai Medicine excels in the manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. Their commitment to innovation and quality has positioned them as a trusted supplier in the global market. Notable for their extensive portfolio, which includes unique formulations and generics, Shengtai Medicine continues to achieve recognition for its contributions to healthcare, ensuring patient safety and efficacy in treatment options.
DitchCarbon Score
How does Shengtai Medicine's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shengtai Medicine's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shengtai Medicine's reported carbon emissions
Shengtai Medicine, headquartered in CN, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of documented reduction initiatives or climate pledges suggests that Shengtai Medicine may still be in the early stages of developing a comprehensive sustainability strategy. As the pharmaceutical industry increasingly prioritises climate action, it will be essential for Shengtai Medicine to establish measurable targets and transparent reporting to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shengtai Medicine is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
